retatrutide phase 2 nejm 2023 obesity trial jastreboff Medscape | The investigational triple GLP-1/GIP/glucagon receptor agonist produced significant weight loss and A1c reduction in people Retatrutide Availability & Timeline |

Tirzepatide: Patients lost 20% of their body weight over 72 weeks with 15 mg injections

GLP-1, or glucagon-like peptide-1, is a naturally occurring hormone in the body that plays a crucial role in regulating blood sugar, appetite, and digestion

doi: 10.1056/NEJMoa1411892 11 NogueirasRNauckMATschopMH

No action is needed from providers at this time

At 43, Chauche was prescribed a weight-loss medication called Wegovyone of a new class of drugs that mimic a hormone responsible for insulin production

Interestingly, rs1165196 variants have little effect onpatients with normal renal excretion (JadeHollis-Moffatt et al., 2012